Mashael S Alfaifi
Overview
Explore the profile of Mashael S Alfaifi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan B, Qahwaji R, Alfaifi M, Athar T, Khan A, Mobashir M, et al.
Sci Rep
. 2024 Nov;
14(1):28794.
PMID: 39567714
Breast cancer is caused by aberrant breast cells that proliferate and develop into tumors. Tumors have the potential to spread throughout the body and become lethal if ignored. Metastasis is...
2.
El-Kady A, Altwaim S, Wakid M, Banjar A, Mohammed K, Alfaifi M, et al.
Front Vet Sci
. 2024 Oct;
11:1443267.
PMID: 39439825
Background: Schistosomiasis affects approximately 250 million people worldwide, with 200,000 deaths annually. It has been documented that the granulomatous response to () oviposition is the root cause of progressive liver...
3.
El-Kady A, Elshazly H, Alsulami M, Albohiri H, Alshehri E, Alfaifi M, et al.
Acta Parasitol
. 2024 Sep;
69(4):1785-1800.
PMID: 39225734
Background: Toxoplasma gondii (T. gondii) infects one third of the world's population with significant illness, mainly among immunocompromised individuals and pregnant women. Treatment options for toxoplasmosis are limited which signifies...
4.
Khan B, Qahwaji R, Alfaifi M, Mobashir M
Pharmaceutics
. 2024 Jun;
16(6).
PMID: 38931856
Combining immune checkpoint inhibitors, specifically nivolumab (anti-PD-1) and ipilimumab (anti-CTLA-4), holds substantial promise in revolutionizing cancer treatment. This review explores the transformative impact of these combinations, emphasizing their potential for...
5.
Gattan H, Wakid M, Qahwaji R, Altwaim S, Mahjoub H, Alfaifi M, et al.
Front Vet Sci
. 2024 May;
11:1407833.
PMID: 38779036
[This corrects the article DOI: 10.3389/fvets.2024.1374116.].
6.
Alfaifi M
Cureus
. 2024 May;
16(4):e57851.
PMID: 38721199
The oncogenic potential of human papillomavirus (HPV) has been widely acknowledged in relation to multiple types of cancer. The objective of this investigation was to conduct a comprehensive assessment of...
7.
Gattan H, Wakid M, Qahwaji R, Altwaim S, Mahjoub H, Alfaifi M, et al.
Front Vet Sci
. 2024 Mar;
11:1374116.
PMID: 38515537
Background: Cryptosporidiosis is an opportunistic parasitic disease widely distributed worldwide. Although sp. causes asymptomatic infection in healthy people, it may lead to severe illness in immunocompromised individuals. Limited effective therapeutic...
8.
El-Kady A, Hassan A, Mohamed K, Alfaifi M, Elshazly H, Alamri Z, et al.
PLoS Negl Trop Dis
. 2023 Jul;
17(7):e0011447.
PMID: 37410712
Background: Although, approximately 30% of the world's population is estimated to be infected with Toxoplasma gondii (T. gondii) with serious manifestations in immunocompromised patients and pregnant females, the available treatment...
9.
Nour M, Natto H, Sinky T, Alfaifi M, Alharbi M, Allahyani A, et al.
Heliyon
. 2023 Mar;
9(3):e13894.
PMID: 36923845
Background: Mobile phones have become part of everyday life with a potential risk for microbial transmission. Makkah is a mass gathering city that may act as hotspots of disease transmission....
10.
El-Kady A, Alzahrani A, Elshazly H, Alshehri E, Wakid M, Gattan H, et al.
Biomedicines
. 2023 Jan;
11(1).
PMID: 36672526
Background: Previous studies have reported involvement of ( infections in the pathogenesis of some autoimmune diseases, such as polymyositis, rheumatoid arthritis, autoimmune thyroiditis, and Crohn's disease. However, data on the...